arrow_back Trending Legislation
Share share

Splitting the National Institute of Allergy and Infectious Diseases into three research bodies

This Act divides the existing National Institute of Allergy and Infectious Diseases (NIAID) into three new research institutes: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases. The change aims to separate research on allergies, infectious diseases, and immunologic disorders. Directors of the new institutes will be appointed by the President with the advice and consent of the Senate for 5-year terms.
Key points
The single NIAID is replaced by three separate bodies: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases.
Directors of the three new institutes will be appointed by the President and confirmed by the Senate for 5-year terms (renewable once).
Research on infectious diseases (including tropical diseases), allergic diseases, and immunologic disorders will be separated among the new institutes.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
NIH Reform Act
Print number: S 960
Sponsor: Sen. Paul, Rand [R-KY]
Process start date: 2023-03-23
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Splitting the National Institute of Allergy and Infectious Diseases into three research bodies

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 960.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-03-23.

What are the main provisions?

Key points include:

  • The single NIAID is replaced by three separate bodies: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases.
  • Directors of the three new institutes will be appointed by the President and confirmed by the Senate for 5-year terms (renewable once).
  • Research on infectious diseases (including tropical diseases), allergic diseases, and immunologic disorders will be separated among the new institutes.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Paul, Rand [R-KY].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

Analysis and Potential Impact of S 960

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health